Lambert-Eaton myasthenic syndrome developing post-diagnosis of small-cell lung cancer

Intern Med J. 2018 Dec;48(12):1541-1542. doi: 10.1111/imj.14128.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antineoplastic Agents / administration & dosage
  • Carboplatin / administration & dosage*
  • Diagnosis, Differential
  • Disease Progression
  • Etoposide / administration & dosage*
  • Humans
  • Lambert-Eaton Myasthenic Syndrome* / diagnosis
  • Lambert-Eaton Myasthenic Syndrome* / etiology
  • Lambert-Eaton Myasthenic Syndrome* / physiopathology
  • Lung Neoplasms* / complications
  • Lung Neoplasms* / drug therapy
  • Lung Neoplasms* / pathology
  • Male
  • Neoplasm Staging
  • Neurologic Examination / methods
  • Prognosis
  • Small Cell Lung Carcinoma* / drug therapy
  • Small Cell Lung Carcinoma* / pathology
  • Terminal Care / methods

Substances

  • Antineoplastic Agents
  • Etoposide
  • Carboplatin